By
Latest Stories
Don’t miss our hot and upcoming stories
BullFrog AI and Eleison Pharmaceuticals Collaborate to Optimize Phase 3 Oncology Trial
Gaithersburg, Md – Feb 27 2025 BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW), a leading…
Incyte and Genesis Therapeutics Forge AI-Driven Partnership to Advance Small Molecule Drug Discovery
BURLINGAME, California – Feb 20, 2025 Accelerating Innovation with AI-Powered Drug Design Incyte (Nasdaq: INCY)…
AI-Powered Insilico Medicine Doses First Patient in Phase I Trial for ISM6331, Pan-TEAD Inhibitor, Targeting Mesothelioma and Solid Tumors
Cambridge, Mass. — Jan 22, 2025 Insilico Medicine, a biotechnology company leveraging generative artificial intelligence…
Insilico Medicine’s AI Platform Unveils GBP2 and HCK as Promising Targets for Endometriosis Treatment
InSilico Medicine — Jan 15, 2025AI-Driven Research Unveils New Therapeutic Approaches Researchers have leveraged artificial…